Advisory Services Network’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.47M | Buy |
13,024
+1,091
| +9% | +$205K | 0.03% | 625 |
|
|
2026
Q1 | $2.35M | Buy |
11,933
+1,674
| +16% | +$323K | 0.03% | 582 |
|
|
2025
Q4 | $1.9M | Buy |
10,259
+163
| +2% | +$28.6K | 0.03% | 618 |
|
|
2025
Q3 | $1.55M | Buy |
10,096
+128
| +1% | +$19.4K | 0.02% | 687 |
|
|
2025
Q2 | $1.46M | Buy |
9,968
+188
| +2% | +$26.3K | 0.02% | 675 |
|
|
2025
Q1 | $1.44M | Buy |
9,780
+15
| +0.2% | +$2.17K | 0.03% | 621 |
|
|
2024
Q4 | $1.28M | Sell |
9,765
-1,040
| -10% | -$146K | 0.02% | 641 |
|
|
2024
Q3 | $1.69M | Hold |
10,805
| – | – | 0.03% | 523 |
|
|
2024
Q2 | $1.69M | Buy |
10,805
+2,299
| +27% | +$346K | 0.03% | 523 |
|
|
2024
Q1 | $1.15M | Buy |
8,506
+1,599
| +23% | +$212K | 0.03% | 636 |
|
|
2023
Q4 | $930K | Buy |
6,907
+2,230
| +48% | +$290K | 0.02% | 661 |
|
|
2023
Q3 | $633K | Buy |
4,677
+65
| +1% | +$8.88K | 0.02% | 812 |
|
|
2023
Q2 | $660K | Sell |
4,612
-2,514
| -35% | -$370K | 0.02% | 801 |
|
|
2023
Q1 | $989K | Sell |
7,126
-106
| -1% | -$14.3K | 0.03% | 616 |
|
|
2022
Q4 | $981K | Sell |
7,232
-724
| -9% | -$90.8K | 0.03% | 601 |
|
|
2022
Q3 | $873K | Buy |
7,956
+348
| +5% | +$44.1K | 0.03% | 588 |
|
|
2022
Q2 | $1M | Buy |
7,608
+3,021
| +66% | +$396K | 0.03% | 560 |
|
|
2022
Q1 | $609K | Buy |
4,587
+1,381
| +43% | +$166K | 0.02% | 829 |
|
|
2021
Q4 | $373K | Sell |
3,206
-680
| -17% | -$80K | 0.01% | 1002 |
|
|
2021
Q3 | $467K | Buy |
3,886
+503
| +15% | +$58.6K | 0.01% | 909 |
|
|
2021
Q2 | $405K | Sell |
3,383
-222
| -6% | -$24.4K | 0.01% | 960 |
|
|
2021
Q1 | $358K | Sell |
3,605
-3,010
| -46% | -$303K | 0.01% | 955 |
|
|
2020
Q4 | $661K | Buy |
6,615
+1,816
| +38% | +$192K | 0.03% | 633 |
|
|
2020
Q3 | $526K | Buy |
4,799
+624
| +15% | +$69.4K | 0.02% | 607 |
|
|
2020
Q2 | $442K | Buy |
4,175
+649
| +18% | +$67K | 0.02% | 641 |
|
|
2020
Q1 | $315K | Sell |
3,526
-330
| -9% | -$31.1K | 0.02% | 656 |
|
|
2019
Q4 | $384K | Buy |
3,856
+669
| +21% | +$63K | 0.02% | 694 |
|
|
2019
Q3 | $263K | Hold |
3,187
| – | – | 0.02% | 746 |
|
|
2019
Q2 | $263K | Buy |
3,187
+169
| +6% | +$13.3K | 0.02% | 744 |
|
|
2019
Q1 | $244K | Sell |
3,018
-312
| -9% | -$24.6K | 0.02% | 727 |
|
|
2018
Q4 | $253K | Buy |
3,330
+285
| +9% | +$22.3K | 0.02% | 635 |
|
|
2018
Q3 | $241K | Sell |
3,045
-239
| -7% | -$18.1K | 0.02% | 712 |
|
|
2018
Q2 | $251K | Sell |
3,284
-376
| -10% | -$27.1K | 0.02% | 682 |
|
|
2018
Q1 | $256K | Buy |
3,660
+500
| +16% | +$34.6K | 0.02% | 701 |
|
|
2017
Q4 | $219K | Buy |
3,160
+1,233
| +64% | +$83.1K | 0.02% | 743 |
|
|
2017
Q3 | $131K | Buy |
1,927
+430
| +29% | +$27.2K | 0.02% | 778 |
|
|
2017
Q2 | $102K | Sell |
1,497
-42
| -3% | -$2.74K | 0.01% | 833 |
|
|
2017
Q1 | $96K | Buy |
+1,539
| New | +$89.6K | 0.01% | 812 |
|
|
2016
Q3 | $33K | Buy |
508
+356
| +234% | +$23.3K | 0.01% | 986 |
|
|
2016
Q2 | $9K | Hold |
152
| – | – | ﹤0.01% | 1226 |
|
|
2016
Q1 | $9K | Sell |
152
-37
| -20% | -$2.22K | ﹤0.01% | 1095 |
|
|
2015
Q4 | $13K | Hold |
189
| – | – | ﹤0.01% | 878 |
|
|
2015
Q3 | $12K | Buy |
189
+57
| +43% | +$3.75K | ﹤0.01% | 863 |
|
|
2015
Q2 | $9K | Hold |
132
| – | – | ﹤0.01% | 879 |
|
|
2015
Q1 | $9K | Hold |
132
| – | – | ﹤0.01% | 839 |
|
|
2014
Q4 | $9K | Buy |
+132
| New | +$9.45K | ﹤0.01% | 759 |
|
|
2014
Q1 | – | Sell |
-1,948
| Closed | -$116K | – | 245 |
|
|
2013
Q4 | $116K | Buy |
+1,948
| New | +$106K | 0.06% | 230 |
|
Other funds holding AZN
EP
IA
Advisory Services Network's AZN Position: Q2 2026 in Review
Advisory Services Network increased its AstraZeneca (AZN) stake by 9.1% in Q2 2026, buying an estimated $205K and bringing the position to 13,024 shares worth $2.47M. The position accounts for 0.03% of the portfolio, ranked #625.
Advisory Services Network first reported a position in AZN in Q4 2013 and has held it in 47 quarters since. 1,495 funds tracked by Wall St. Rank hold AZN as of Q2 2026.
- Advisory Services Network held 13,024 shares of AstraZeneca worth $2.47M as of Q2 2026.
- Advisory Services Network bought 1,091 AstraZeneca shares in Q2 2026, an estimated $205K.
- AstraZeneca made up 0.03% of Advisory Services Network's portfolio in Q2 2026, its #625 holding.
- Advisory Services Network first reported a position in AstraZeneca in Q4 2013 and has held it in 47 quarters since.
- 1,495 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.
Based on Advisory Services Network's 13F filing for Q2 2026, filed 12 Aug 2026.